Design of an open-label extension trial of nerandomilast (BI 1015550) in patients with idiopathic pulmonary fibrosis and progressive pulmonary fibrosis (FIBRONEER™-ON)
Year: 2025
Type: article
Language: en
Topic: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Authors and affiliations:
raw_author_name: Wim A. Wuyts
raw_affiliation_strings: Department of Respiratory Medicine, Unit for Interstitial Lung Diseases, University Hospitals Leuven, Herestraat 49, Leuven, 3000, Belgium. wim.wuyts@uzleuven.be
Department of Respiratory Medicine, Unit for Interstitial Lung Diseases, University Hospitals Leuven, Herestraat 49, Leuven, 3000, Belgium
raw_author_name: Luca Richeldi
raw_affiliation_strings: Unità Operativa Complessa di Pneumologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy
raw_author_name: Shervin Assassi
raw_affiliation_strings: Division of Rheumatology, McGovern Medical School, University of Texas, Houston, TX, USA
raw_author_name: Arata Azuma
raw_affiliation_strings: Pulmonary Medicine and Oncology, Nippon Medical School, Tokyo, Japan
Pulmonary Research Center, Mihara General Hospital, Saitama, Japan
raw_author_name: Vincent Cottin
raw_affiliation_strings: Hôpital Louis Pradel, Centre de Référence des Maladies Pulmonaires Rares, Hospices Civils de Lyon, UMR 754, INRAE, ERN-LUNG, Université Claude Bernard Lyon 1, Lyon, France
raw_author_name: Anna-Maria Hoffmann-Vold
raw_affiliation_strings: Department of Rheumatology, Oslo University Hospital, Oslo, Norway
raw_author_name: Michael Kreuter
raw_affiliation_strings: Department of Pneumology, Mainz Center for Pulmonary Medicine, Mainz University Medical Center, Mainz, Germany
Department of Pulmonary, Critical Care & Sleep Medicine, Marienhaus Clinic Mainz, Mainz, Germany
raw_author_name: Justin M. Oldham
raw_affiliation_strings: Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Abor, MI, USA
raw_author_name: Fernando J. Martinez
raw_affiliation_strings: Department of Medicine, Cornell University, New York City, NY, USA
raw_author_name: Claudia Valenzuela
raw_affiliation_strings: ILD Unit, Pulmonology Department, Hospital Universitario de la Princesa, University Autonomade Madrid, Madrid, Spain
raw_author_name: Marlies S. Wijsenbeek
raw_affiliation_strings: Department of Respiratory Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
raw_author_name: Madhu Kanakapura
raw_affiliation_strings: Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany
raw_author_name: Alexandra James
raw_affiliation_strings: Elderbrook Solutions GmbH, Bietigheim-Bissingen, Germany
raw_author_name: Gerrit Weimann
raw_affiliation_strings: Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany
Boehringer Ingelheim International GmbH,  Ingelheim am Rhein, Germany
raw_author_name: Cyril Drzewuski
raw_affiliation_strings: Boehringer Ingelheim, Reims, France
raw_author_name: Carl Coeck
raw_affiliation_strings: Boehringer Ingelheim SComm, Brussels, Belgium
raw_author_name: Toby M. Maher
raw_affiliation_strings: Keck Medicine of USC, Los Angeles, CA, USA
National Heart and Lung Institute, Imperial College London, London, UK